menu
    • menu

    Company profile for Respira Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Respira develops unique inhaled therapeutic products that address significant unmet patient needs. Respira applies industry-leading experience and expertise to develop pulmonary products that have a high probability of technical and clinical success. Our initial focus is on 505b2 products that we believe will improve the standard of care. We selectively partner with companies that have unique pulmonary delivery challenges. We...
    Respira develops unique inhaled therapeutic products that address significant unmet patient needs. Respira applies industry-leading experience and expertise to develop pulmonary products that have a high probability of technical and clinical success. Our initial focus is on 505b2 products that we believe will improve the standard of care. We selectively partner with companies that have unique pulmonary delivery challenges. We have developed a novel, easy-to-use, and reliable dry-powder inhalation device (AOS™ DPI) and apply advanced particle engineering formulation technologies to create products.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Respira TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5901 Indian School Road NE #107 Albuquerque, NM 87110 505 200-9557
    Telephone
    Telephone
    (505) 200-9557
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://respiratherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/respira-therapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Respira Therapeutics Enters into Agreement with Gossamer Bio
    Respira Therapeutics Enters into Agreement with Gossamer Bio

    25 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/respira-therapeutics-enters-into-agreement-with-gossamer-bio-gossamer-granting-gossamer-option-to-acquire-respira-from-samsara-biocapital-302567055.html

    PR NEWSWIRE
    25 Sep 2025
    Share Share
    Respira Therapeutics to Present RT234 Phase 2b PAH Trial Results
    Respira Therapeutics to Present RT234 Phase 2b PAH Trial Results

    19 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/19/3083950/0/en/Respira-Therapeutics-Announces-Late-breaking-Presentation-of-RT234-Phase-2b-PAH-Clinical-Trial-Results-at-the-American-Thoracic-Society-ATS-2025-International-Conference.html

    GLOBENEWSWIRE
    19 May 2025
    Share Share
    Health tech company throws out overused name as it rebrands to Qnovia
    Health tech company throws out overused name as it rebrands to Qnovia

    16 Sep 2022

    // FIERCEPHARMA

    https://www.fiercepharma.com/marketing/too-many-respiras-smoking-cessation-health-tech-company-throws-out-overused-name-it

    FIERCEPHARMA
    16 Sep 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search